Back

FDA finalizes Expedited IND Pilot to speed first-in-human trials

Verifying
  • FDA finalized the Expedited IND Pilot for drug sponsors and qualified research institutions.
  • October 30, 2026, is the application deadline; 8–10 pairs are expected initially.
  • The pilot enables rolling pre-IND review while FDA retains full regulatory authority.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
FDA finalizes Expedited IND Pilot to speed first-in-human trials - CoinPost Terminal